BioAdvance Capital
HQPhiladelphia, PA, US
Check size๐ Free account
Fund details๐ Free account
Partner contacts๐ Pro
Thesis
Evergreen Mid-Atlantic fund investing $500K to $1.5M in seed and Series A life science companies.
Stages
SeedSeries A
Sectors
BiotechLife SciencesHealthcare/MedtechHealth and WellnessAnalytics
Partners & verified contacts
Investor IntelligenceInvestor Intelligence opens the partners at BioAdvance Capital, their roles, and verified emails that reach them.
See Investor Intelligence โ